Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): Relationships with adverse outcomes

Angela Falbo, Morena Rocca, Tiziana Russo, Antonietta D'Ettore, Achille Tolino, Fulvio Zullo, Francesco Orio, Stefano Palomba

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Given the high rate of pregnancy and perinatal complications recently observed in patients with polycystic ovary syndrome (PCOS) and the lack of data on the serum variations in androgens and insulin sensitivity indexes in pregnant women with PCOS, the current study was aimed to assess these changes and their potential effect on pregnancy outcomes in a population of women with PCOS. Methods: Forty-five pregnant patients with ovulatory PCOS (PCOS group) and other 42 healthy pregnant women (control group) were studied assaying serum androgen levels and insulin sensitivity indexes throughout pregnancy serially, and recording obstetrical outcomes. Results: Serum androgen levels and insulin resistance indexes were significantly (p <0.05) higher in PCOS than in control group at study entry, these differences were sustained throughout pregnancy, and their changes resulted significantly (p <0.05) different between PCOS and control group. In PCOS patients, women who had a complicated pregnancy showed serum androgen levels and insulin sensitivity indexes significantly (p <0.05) worse in comparison to subjects without any pregnancy and/or neonatal complications. Conclusions: PCOS patients have impaired changes in serum androgen levels and insulin sensitivity indexes during pregnancy. These alterations could be implicated in the pregnancy and neonatal complications frequently observed in women affected by PCOS.

Original languageEnglish
Article number23
JournalJournal of Ovarian Research
Volume3
Issue number1
DOIs
Publication statusPublished - 2010

Fingerprint

Polycystic Ovary Syndrome
Androgens
Insulin Resistance
Pregnancy
Serum
Pregnancy Complications
Control Groups
Pregnant Women
Pregnancy Outcome

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS) : Relationships with adverse outcomes. / Falbo, Angela; Rocca, Morena; Russo, Tiziana; D'Ettore, Antonietta; Tolino, Achille; Zullo, Fulvio; Orio, Francesco; Palomba, Stefano.

In: Journal of Ovarian Research, Vol. 3, No. 1, 23, 2010.

Research output: Contribution to journalArticle

Falbo, Angela ; Rocca, Morena ; Russo, Tiziana ; D'Ettore, Antonietta ; Tolino, Achille ; Zullo, Fulvio ; Orio, Francesco ; Palomba, Stefano. / Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS) : Relationships with adverse outcomes. In: Journal of Ovarian Research. 2010 ; Vol. 3, No. 1.
@article{a049f26fb7e6465388333fe4c482e415,
title = "Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): Relationships with adverse outcomes",
abstract = "Background: Given the high rate of pregnancy and perinatal complications recently observed in patients with polycystic ovary syndrome (PCOS) and the lack of data on the serum variations in androgens and insulin sensitivity indexes in pregnant women with PCOS, the current study was aimed to assess these changes and their potential effect on pregnancy outcomes in a population of women with PCOS. Methods: Forty-five pregnant patients with ovulatory PCOS (PCOS group) and other 42 healthy pregnant women (control group) were studied assaying serum androgen levels and insulin sensitivity indexes throughout pregnancy serially, and recording obstetrical outcomes. Results: Serum androgen levels and insulin resistance indexes were significantly (p <0.05) higher in PCOS than in control group at study entry, these differences were sustained throughout pregnancy, and their changes resulted significantly (p <0.05) different between PCOS and control group. In PCOS patients, women who had a complicated pregnancy showed serum androgen levels and insulin sensitivity indexes significantly (p <0.05) worse in comparison to subjects without any pregnancy and/or neonatal complications. Conclusions: PCOS patients have impaired changes in serum androgen levels and insulin sensitivity indexes during pregnancy. These alterations could be implicated in the pregnancy and neonatal complications frequently observed in women affected by PCOS.",
author = "Angela Falbo and Morena Rocca and Tiziana Russo and Antonietta D'Ettore and Achille Tolino and Fulvio Zullo and Francesco Orio and Stefano Palomba",
year = "2010",
doi = "10.1186/1757-2215-3-23",
language = "English",
volume = "3",
journal = "Journal of Ovarian Research",
issn = "1757-2215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS)

T2 - Relationships with adverse outcomes

AU - Falbo, Angela

AU - Rocca, Morena

AU - Russo, Tiziana

AU - D'Ettore, Antonietta

AU - Tolino, Achille

AU - Zullo, Fulvio

AU - Orio, Francesco

AU - Palomba, Stefano

PY - 2010

Y1 - 2010

N2 - Background: Given the high rate of pregnancy and perinatal complications recently observed in patients with polycystic ovary syndrome (PCOS) and the lack of data on the serum variations in androgens and insulin sensitivity indexes in pregnant women with PCOS, the current study was aimed to assess these changes and their potential effect on pregnancy outcomes in a population of women with PCOS. Methods: Forty-five pregnant patients with ovulatory PCOS (PCOS group) and other 42 healthy pregnant women (control group) were studied assaying serum androgen levels and insulin sensitivity indexes throughout pregnancy serially, and recording obstetrical outcomes. Results: Serum androgen levels and insulin resistance indexes were significantly (p <0.05) higher in PCOS than in control group at study entry, these differences were sustained throughout pregnancy, and their changes resulted significantly (p <0.05) different between PCOS and control group. In PCOS patients, women who had a complicated pregnancy showed serum androgen levels and insulin sensitivity indexes significantly (p <0.05) worse in comparison to subjects without any pregnancy and/or neonatal complications. Conclusions: PCOS patients have impaired changes in serum androgen levels and insulin sensitivity indexes during pregnancy. These alterations could be implicated in the pregnancy and neonatal complications frequently observed in women affected by PCOS.

AB - Background: Given the high rate of pregnancy and perinatal complications recently observed in patients with polycystic ovary syndrome (PCOS) and the lack of data on the serum variations in androgens and insulin sensitivity indexes in pregnant women with PCOS, the current study was aimed to assess these changes and their potential effect on pregnancy outcomes in a population of women with PCOS. Methods: Forty-five pregnant patients with ovulatory PCOS (PCOS group) and other 42 healthy pregnant women (control group) were studied assaying serum androgen levels and insulin sensitivity indexes throughout pregnancy serially, and recording obstetrical outcomes. Results: Serum androgen levels and insulin resistance indexes were significantly (p <0.05) higher in PCOS than in control group at study entry, these differences were sustained throughout pregnancy, and their changes resulted significantly (p <0.05) different between PCOS and control group. In PCOS patients, women who had a complicated pregnancy showed serum androgen levels and insulin sensitivity indexes significantly (p <0.05) worse in comparison to subjects without any pregnancy and/or neonatal complications. Conclusions: PCOS patients have impaired changes in serum androgen levels and insulin sensitivity indexes during pregnancy. These alterations could be implicated in the pregnancy and neonatal complications frequently observed in women affected by PCOS.

UR - http://www.scopus.com/inward/record.url?scp=77957735148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957735148&partnerID=8YFLogxK

U2 - 10.1186/1757-2215-3-23

DO - 10.1186/1757-2215-3-23

M3 - Article

C2 - 20942923

AN - SCOPUS:77957735148

VL - 3

JO - Journal of Ovarian Research

JF - Journal of Ovarian Research

SN - 1757-2215

IS - 1

M1 - 23

ER -